Frontline DNA-Repair Inhibition as Maintenance in High-Risk Ovarian Carcinoma. International Journal of Clinical Research and Medical Sciences, [S. l.], v. 1, n. 3, 2026. DOI: 10.67231/4gks8p50. Disponível em: https://journals.femington.com/ijcrms/article/view/18. Acesso em: 8 nov. 2026.